EMA to provide further context on risk of blood... : vimarsa

© In-Cyprus 2021
EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination with Vaxzevria (formerly COVID-19 Vaccine AstraZeneca).
In line with a request from the EU’s Commissioner for Health and Food Safety following a meeting of EU Health Ministers, EMA is undertaking a review of vaccination data and data on disease epidemiology (including infection rates, hospitalisations, morbidity and mortality).
The review by EMA’s human medicines committee (CHMP) will enable authorities to put the risks of Vaxzevria into the context of the benefits of ongoing vaccination...

Related Keywords

, Eu Health Ministers , Food Safety , Provide , Further , Context , Blood , Clots , Regarding , Astrazeneca , Vaccine , யூ ஆரோக்கியம் அமைச்சர்கள் , உணவு பாதுகாப்பு , வழங்க , மேலும் , சூழல் , இரத்தம் , தொடர்பாக , தடுப்பூசி ,